Moti Chapagain, MD, PhD

Director
Praedicare Inc.

Disclosure(s): Praedicare Inc.: Stocks/Bonds

Poster(s):

• 1697 - Dose-response Studies of the Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Epetraborole, in the Intracellular Hollow Fiber System Model of Mycobacterium avium complex Lung Disease
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET